{"schema_version":"secwatch.filing_event.v1","accession":"0001770787-25-000058","form_type":"8-K","ticker":"TXG","cik":"0001770787","company_name":"10x Genomics, Inc.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.377239+00:00","generated_at":"2026-05-16T23:53:39.962645+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"10x Genomics Q3 revenue $149M (-2% YoY); guides Q4 $154-158M","bullets":["Revenue $149.0M in Q3 2025, down 2% YoY; gross margin 67% vs 70% prior year.","Operating loss improved to $32.2M from $41.5M; net loss $27.5M vs $35.8M.","Cash and marketable securities $482.1M, up $35M sequentially.","Q4 2025 revenue guidance $154-158M (midpoint 6% decline YoY, 5% sequential growth).","Launched next-gen Chromium Flex and Xenium Protein spatial multiomic workflow."],"urls":{"canonical":"https://secwatch.observer/filing/0001770787-25-000058","json":"https://secwatch.observer/filing/0001770787-25-000058.json","markdown":"https://secwatch.observer/filing/0001770787-25-000058.md","text":"https://secwatch.observer/filing/0001770787-25-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770787/000177078725000058/0001770787-25-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770787/000177078725000058/txg-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:53:39.962645+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}